Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Net Income 2024–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2024 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cyclacel Pharmaceuticals, Inc. net income for the quarter ending March 31, 2026 was -197000, a 143.21% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. net income for the twelve months ending March 31, 2026 was -3.1 M.
- Cyclacel Pharmaceuticals, Inc. annual net income for 2025 was -3.0 M, a 73.26% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. annual net income for 2024 was -11.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclacel Pharmaceuticals, Inc. Net Income — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s net income?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported net income of -$3M for fiscal 2025.
Where can I see BGMS's net income history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.